L-Carnitine inhibits protein glycation in vitro and in vivo: Evidence for a role in diabetic management

Acta Diabetologica

Volumn 44, Issue 2, 2007, Pages 83-90

  Rajasekar, P ^a   Anuradha, C V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Collagen; Diaphragm; Glucose utilisation; Glycation; L Carnitine

Indexed keywords

AMINOGUANIDINE; BOVINE SERUM ALBUMIN; CARNITINE; COLLAGEN; FRUCTOSAMINE; FRUCTOSE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CONTROLLED STUDY; DIABETES MELLITUS; DIAPHRAGM; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; SKIN; STATISTICAL SIGNIFICANCE; TENDON;

ANIMALS; BLOOD GLUCOSE; CARNITINE; DIABETES MELLITUS; DIAPHRAGM; DIETARY CARBOHYDRATES; FRUCTOSAMINE; FRUCTOSE; GLYCOLYSIS; GLYCOSYLATION; GUANIDINES; KINETICS; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE;

EID: 34249709372     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0247-5     Document Type: Article

References (54)

1. Bucala R, Cerami A (1992) Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23:1-34
2. Vlassara H, Bucala R, Striker L (1994) Pathogenic effect of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. J Lab Invest 70:138-151
3. Turk Z (1997) Advanced glycation toxicity and diabetic complications. Diabetologia Croatica 26:11-26
4. Ahmed N (2005) Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 67:3-21
5. Blakytny R, Harding JJ (1992) Prevention of cataract in diabetic rat by aspirin, paracetamol and ibuprofen. Exp Eye Res 54:509-518
6. Frank T, Bitsch R, Maiwald J, Stein G (2000) High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfotiamine. Eur J Clin Pharmacol 56:251-257
7. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826-2832
8. Hammes H, Strodter D, Weiss A, Bretzel R, Federlin KMB (1995) Secondary intervention with aminoguanidine retards in the progression of diabetic retinopathy in the rat model. Diabetologia 38:656-660
9. Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M (1997) Acquired carnitine abnormalities in critically ill children. Eur J Pediatr 156:864-869
10. Tamamogullari N, Silig Y, Icagasioglu S, Atalay A (1999) Carnitine deficiency in diabetes mellitus complications. J Diabetes Complications 13:251-253
11. Rajasekar P, Kaviarasan S, Anuradha CV (2005) L-Carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetologia Croatica 34:21-28
12. Dayanandan A, Kumar P, Panneerselvam C (2001) Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J Nutr Biochem 12:254-257
13. Rao P, Pattabiraman TN (1990) Further studies on the mechanism of phenol sulfuric acid reaction with furfuraldehyde derivatives. Anal Biochem 189:178-181
14. Rao JH (1934) A colorimetric method for the determination of fructose in blood and urine. J Biol Chem 107:15-22
15. Johnson RN, Metealf PA, Baker JR (1983) Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chem Acta 217:87-95
16. Gilbert RP, Brandt RB (1975) Spectrophotometric determination of methyl glyoxal with 2,4-dinotophenylhydrazine. Anal Chem 47:14
17. Woessner JF (1961) The determination of hydroxyproline in tissue and protein samples containing small portions of this imino acid. Arch Biochem Biophys 93:440-447
18. Vinson AJ, Howard BT (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7:659-663
19. Yanagisawa K, Makita Z, Shiroshita K, Ueda T, Fusegawa T, Kuwajima S, Takeuchi M, Koike T (1998) Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 47:1348-1353
20. Haugaard N, Haugaard SE (1970) Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim Biophys Acta 222:583-586
21. Yan S, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J Biol Chem 269:9889-9897
22. Fu MX, Wells-Kencht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW (1994) Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43:676-683
23. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S (1998) Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 181:1-9
24. Levi B, Werman, MJ (1998) Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr 128:1442-1449
25. Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S (1997) Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 127:103-107
26. Bunn HF, Higgins PJ (1981) Reaction of monosaccharides with proteins: possible evolutionary significance. Science 213:222-224
27. Kawasaki Y, Fujii J, Miyazawa N, Hoshi A, Okado A, Tano Y, Taniguchi N (1998) Specific detections of the early process of the glycation reaction by fructose and glucose in diabetic rat lens. FEBS Lett 441:116-120
28. Shinozaki K, Okamura T, Nishio Y, Kashiwagi A, Kikkawa R, Toda N (2000) Evaluation of endothelial free radical release by vascular tension responses in insulin-resistant rat aorta. Euro J Pharmacol 394:295-299
29. Balakrishnan SD, Anuradha CV (1999) Taurine supplementation attenuates erythrocyte lipid peroxidation in fructose-fed hypertensive rats. Med Sci Res 27:489-492
30. Anitha Nandhini AT, Balakrishnan SD, Anuradha CV (2002) Response of liver antioxidant system to taurine in rats fed high fructose diet. Indian J Exp Biol 40:1016-1019
31. Levi B, Werman MJ (2001) Fructose triggers DNA modification and damage in an Escherichia coli plasmid. J Nutr Biochem 12:235-241
32. Suzuki K, Islam KN, Kaneto H, Ookawara T, Taniguchi N (2000) The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase. Electrophoresis 21:285-288
33. Levi B, Werman MJ (2003) Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells. J Nutr Biochem 4:49-60
34. Zhao W, Devamanoharan PS, Varma SD (2000) Fructose induced deactivation of antioxidant enzymes: preventive effect of pyruvate. Free Radic Res 33:23-30
35. Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173:932-939
36. Brownlee M (1986) Negative consequences of glycation. Metabolism 49[Suppl 1]:S9-S13
37. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1991) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation endproducts is mediated by PDGF. Proc Natl Acad Sci USA 89:2873-2877
38. Farielo RG, Ferrano TG, Golden GT, Demattei M (1988) Systemic acetyl-L-carnitine elevates nigral levels of glutathion and GABA. Life Sci 43:289-292
39. Arockiyarani JP, Panneerselvam C (2001) Carnitine as a free radical scavenger in aging. Exp Gerontol 36:1713-1726
40. Reznick AZ, Kagan VE, Ramsey R, Tsuchiya M, Khwaja S, Serbinova EA, Packer L (1992) Antiradical effects in L-propionyl carnitine, protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch Biochem Biophys 296:394-401
41. Conti P, Reale M, Stuard S, Spoto G, Picerno F, Ferrara T, Placido FC, Barbaccane RC, Albertazzi A, Errichi BM (1994) Reduced human lymphocyte blastogenesis and enhancement of adenosine triphosphate by L-carnitine. Mol Cell Biochem 131:1-8
42. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F (1988) Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255:E946-E952
43. Broderick TL, Quinuey HA, Lopaschuk GD (1992) Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267:3758-3763
44. Devynck MA (1995) Do cell membrane dynamica participate in insulin resistance? Lancet 345:336-337
45. Virmani MA, Caso V, Spadoni A, Rossi S, Russo F, Gaetani F (2001) The action of acetyl-Lcarnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurones. Annu N Y Acad Sci 939:162-178
46. Beisswenger PJ, Howell SK, Odell RM, Wood ME, Touchette AD, Szwergold BS (2001) Alpha-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24:726-732
47. Chen H, Cerami A (1993) Mechanism of inhibition of advanced glycosylation by aminoguanidine in vitro. J Carbohydr Chem 12:731-742
48. Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632
49. Whittier F, Spinowitz B, Wuerth JP, Cartwright K (1999) Pimagedine safety profiles in patients with type 1 diabetes mellitus. J Am Soc Nephrol 10:184A
50. Poorabbas A, Bagdadchi J, Fallah F, Mahdavi R, Aliasgarzadeh A, Asadi Y, Koushavar H (2004) Assessment of free L-carnitine levels in type II diabetic women with and without complications. Asia Pac J Clin Nutr 13[Suppl]:S155
51. Mamoulakis D, Galanakis E, Dionyssopoulou E, Evangeliou A, Sbyrakis S (2004) Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications 18:271-274
52. Ido Y, McHowat J, Chang KC, Arrigoni-Martelli E, Orfalian Z, Kilo C, Corr PB Williamson JR (1994) Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L-carnitine. Diabetes 43:1469-1477
53. Nakamura J, Koh N, Sakakibara F, Hamada Y, Hara T, Sasaki H, Chaya S, Komori T, Nakashima E, Naruse K, Kato K, Takeuchin N, Kasuya Y, Hotta N (1998) Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J Pharmacol Exp Ther 287:897-902
54. Sima AAF, Calvani M, Mehra M, Amato A (2005) Acetyl-Lcarnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy. Diabetes Care 28:96-101